Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor plus DLI for Relapsed Acute Leukemia Post-HSCT
NCT06141304Phase 2Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Sep 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT06141304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06141304.